Vignesh Vudatha

15PUBLICATIONS
58CO-AUTHORS
Molecular targetsIntensive careCancer therapy (excl. chemotherapy and radiation therapy)Oral medicine and pathologyCellular interactions (incl. adhesion, matrix, cell wall)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 28, 2026
The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRAS<sup>G12D</sup> Inhibitor Treatment.

Javed Miyan, Vignesh Vudatha, Lin Cao

|Nov 09, 2024
Unveiling the Promise: Navigating Clinical Trials 1978-2024 for PDAC.

Angel A Dominguez, Matthew T Perz, Yi Xu

|Dec 05, 2023
Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors.

Aslamuzzaman Kazi, Alok Ranjan, Vasantha Kumar M V

|Sep 04, 2023
Percutaneous Dilatational Tracheostomy in a Cardiac Surgical Intensive Care Unit: A Single-Center Experience.

Vignesh Vudatha, Yahya Alwatari, George Ibrahim

|Aug 12, 2023
Race and Ethnicity Impacts Overall Survival of Patients with Appendiceal Cancer Who Undergo Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Devon C Freudenberger, Vignesh Vudatha, Luke G Wolfe

|Jun 28, 2023
Translocation of Oral Microbiota into the Pancreatic Ductal Adenocarcinoma Tumor Microenvironment.

Kelley N L McKinley, Kelly M Herremans, Andrea N Riner

Pageof 3

Frequent Collaborators

7 joint publications

Andrea N Riner

6 joint publications

Devon C Freudenberger

6 joint publications

Kelly M Herremans

3 joint publications

Jose Trevino